237 related articles for article (PubMed ID: 19922499)
1. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
Heidt S; Roelen DL; Eijsink C; Eikmans M; van Kooten C; Claas FH; Mulder A
Clin Exp Immunol; 2010 Feb; 159(2):199-207. PubMed ID: 19922499
[TBL] [Abstract][Full Text] [Related]
2. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.
Heidt S; Roelen DL; Eijsink C; van Kooten C; Claas FH; Mulder A
Transplantation; 2008 Nov; 86(9):1292-300. PubMed ID: 19005412
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells.
Kraaijeveld R; Li Y; Yan L; de Leur K; Dieterich M; Peeters AMA; Wang L; Shi Y; Baan CC
Transplant Proc; 2019 Dec; 51(10):3463-3473. PubMed ID: 31733794
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.
De Bruyne R; Bogaert D; De Ruyck N; Lambrecht BN; Van Winckel M; Gevaert P; Dullaers M
Clin Exp Immunol; 2015 Jun; 180(3):542-50. PubMed ID: 25682989
[TBL] [Abstract][Full Text] [Related]
6. Impact of mycophenolic acid and tacrolimus on Th17-related immune response.
Abadja F; Atemkeng S; Alamartine E; Berthoux F; Mariat C
Transplantation; 2011 Aug; 92(4):396-403. PubMed ID: 21818055
[TBL] [Abstract][Full Text] [Related]
7. Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study.
Weimer R; Streller S; Staak A; Heilke M; Li D; Dietrich H; Daniel V; Feustel A; Rainer L; Zinn S; Friemann S; Ernst W; Grimm H; Padberg W; Zimmermann T; Opelz G
Transplant Proc; 2002 Sep; 34(6):2377-8. PubMed ID: 12270445
[No Abstract] [Full Text] [Related]
8. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
9. Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses.
Weimer R; Melk A; Daniel V; Friemann S; Padberg W; Opelz G
Hum Immunol; 2000 Sep; 61(9):884-97. PubMed ID: 11053632
[TBL] [Abstract][Full Text] [Related]
10. Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose.
Steines L; Poth H; Schuster A; Amann K; Banas B; Bergler T
Front Immunol; 2021; 12():657894. PubMed ID: 34135891
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of T-cell apoptosis by immunosuppressive agents.
Takahashi K; Reynolds M; Ogawa N; Longo DL; Burdick J
Clin Transplant; 2004; 18 Suppl 12():72-5. PubMed ID: 15217412
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.
Hajkova M; Hermankova B; Javorkova E; Bohacova P; Zajicova A; Holan V; Krulova M
Stem Cell Rev Rep; 2017 Feb; 13(1):104-115. PubMed ID: 27866327
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
[TBL] [Abstract][Full Text] [Related]
14. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.
Traitanon O; Mathew JM; La Monica G; Xu L; Mas V; Gallon L
PLoS One; 2015; 10(6):e0129658. PubMed ID: 26087255
[TBL] [Abstract][Full Text] [Related]
15. Combined standard and novel immunosuppressive substances affect B-lymphocyte function.
Matz M; Lehnert M; Lorkowski C; Fabritius K; Weber UA; Mashreghi MF; Neumayer HH; Budde K
Int Immunopharmacol; 2013 Apr; 15(4):718-25. PubMed ID: 23499640
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
17. Increased CD40L+PD-1+ follicular helper T cells (Tfh) as a biomarker for predicting calcineurin inhibitor sensitivity against Tfh-mediated B-cell activation/antibody production after kidney transplantation.
Iwasaki K; Kitahata N; Hiramitsu T; Yamamoto T; Noda T; Okada M; Narumi S; Watarai Y; Miwa Y; Uchida K; Matsuoka Y; Horimi K; Kobayashi T
Int Immunol; 2018 Jul; 30(8):345-355. PubMed ID: 29878122
[TBL] [Abstract][Full Text] [Related]
18. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.
Matz M; Lehnert M; Lorkowski C; Fabritius K; Unterwalder N; Doueiri S; Weber UA; Mashreghi MF; Neumayer HH; Budde K
Transpl Int; 2012 Oct; 25(10):1106-16. PubMed ID: 22816666
[TBL] [Abstract][Full Text] [Related]
19. The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo.
Boldt A; Barten MJ; Sagner A; Mohr FW; Adams V; Dhein S; Gummert JF
Transplantation; 2006 Aug; 82(3):422-7. PubMed ID: 16906043
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
